No evidence for therapeutic effect of topical ciclosporin in oral lichen planus: Reply from authors [8]

British Journal of Dermatology

Volumn 155, Issue 2, 2006, Pages 488-

  Carrozzo, M ^a   Conrotto, D ^a   Carbone, M ^a   Gandolfo, S ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CHLORHEXIDINE; CLOBETASOL PROPIONATE; CYCLOSPORIN; HYDROXYETHYLCELLULOSE; MICONAZOLE;

CLINICAL TRIAL; HUMAN; LETTER; LICHEN PLANUS; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SYMPTOM;

EID: 33745907579     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07335.x     Document Type: Letter

References (6)

1. Conrotto D, Carbone M, Carrozzo M et al. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol 2006; 134:139-45.
2. Levell NJ, MacLeod RI, Marks JM. Lack of effect of cyclosporin mouthwash in oral lichen planus. Lancet 1991; 337:796-7.
3. Becherel PA, Chosidow O, Boisnic S et al. Topical cyclosporine in the treatment of oral and vulvar erosive lichen planus: a blood level monitoring study. Arch Dermatol 1995; 131:495-6.
4. Carbone M, Conrotto D, Carrozzo M et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 1999; 5:44-9.
5. Rodstrom PO, Jontell M, Mattson U, Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol 2004; 40:131-8.
6. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46:207-14.